Bass Judith, Neugebauer Richard, Clougherty Kathleen F, Verdeli Helen, Wickramaratne Priya, Ndogoni Lincoln, Speelman Liesbeth, Weissman Myrna, Bolton Paul
Center for International Health and Development, Boston University School of Public Health, 85 East Concord Street, 5th Floor, Boston, MA 02118, USA.
Br J Psychiatry. 2006 Jun;188:567-73. doi: 10.1192/bjp.188.6.567.
A randomised controlled trial comparing group interpersonal psychotherapy with treatment as usual among rural Ugandans meeting symptom and functional impairment criteria for DSM-IV major depressive disorder or sub-threshold disorder showed evidence of effectiveness immediately following the intervention.
To assess the long-term effectiveness of this therapy over a subsequent 6-month period.
A follow-up study of trial participants was conducted in which the primary outcomes were depression diagnosis, depressive symptoms and functional impairment.
At 6 months, participants receiving the group interpersonal psychotherapy had mean depression symptom and functional impairment scores respectively 14.0 points (95% CI 12.2-15.8; P<0.0001) and 5.0 points (95% CI 3.6-6.4; P<0.0001) lower than the control group. Similarly, the rate of major depression among those in the treatment arm (11.7%) was significantly lower than that in the control arm (54.9%) (P<0.0001).
Participation in a 16-week group interpersonal psychotherapy intervention continued to confer a substantial mental health benefit 6 months after conclusion of the formal intervention.
一项随机对照试验比较了团体人际心理治疗与常规治疗在符合DSM-IV重度抑郁症或阈下障碍症状及功能损害标准的乌干达农村人中的效果,结果显示干预后立即有疗效证据。
评估该疗法在随后6个月期间的长期疗效。
对试验参与者进行随访研究,主要结局为抑郁症诊断、抑郁症状及功能损害。
6个月时,接受团体人际心理治疗的参与者的平均抑郁症状和功能损害得分分别比对照组低14.0分(95%可信区间12.2 - 15.8;P<0.0001)和5.0分(95%可信区间3.6 - 6.4;P<0.0001)。同样,治疗组中重度抑郁症的发生率(11.7%)显著低于对照组(54.9%)(P<0.0001)。
在正式干预结束6个月后,参与为期16周的团体人际心理治疗干预仍能带来显著的心理健康益处。